Dr. Ben Fadel is a Neonatologist at the Children’s Hospital of Eastern Ontario (CHEO) and the Ottawa Hospital (TOH) and an Assistant Professor at the University of Ottawa since September 2010. She received her MD from Al Fateh University in Tripoli, Libya.
Dr. Ben Fadel has a great interest in studying neonatal cardiac function and hemodynamics. She always appreciated the role of Targeted Neonatal Echocardiography (TnEcho) in providing real time information about physiology and hemodynamics in the sick newborn and the values of having this information to target cardiovascular support and monitor the response to treatment. Her main research focus is on the use of TnEcho and point of care ultrasound (POCUS) in the Neonatal Intensive Care Unit. She is currently involved in
supervising research by residents and fellows in this important clinical area.
Furthermore, Dr. Ben Fadel has a master’s degree in Health Professional Medical Education and she is the program director of both the Neonatal Perinatal Medicine fellowship and Targeted Neonatal Echocardiography Fellowships.
Impact of a web-based module on trainees’ ability to interpret neonatal cranial ultrasound
A WBL module for teaching neonatal CUS interpretation considerably improved trainees’ knowledge and enhanced their skills in interpreting neonatal CUS.
Target oxygen saturation and development of pulmonary hypertension and increased pulmonary vascular resistance in preterm infants
Higher targeted oxygen saturation was associated with reduced risk of PH or elevated PVR in extremely preterm infants compared to lower oxygen saturation target.
Neonatal ethics teaching program-scenario-oriented learning in ethics: announcing the diagnosis of trisomy 21
The pilot workshop was completed by 21 postgraduate trainees from the University of Ottawa. Qualitative evaluations were overwhelmingly positive, with feedback indicating high levels of perceived usefulness for the workshop.
Resolution of refractory hypotension and anuria in a premature newborn with loss-of-function of ACE
Vasopressin was used to successfully treat refractory hypotension and anuria in the neonate born at 27 weeks of gestation.